{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:37:45Z","timestamp":1793911065122,"version":"4.8.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003524","name":"Ministry of Business, Innovation and Employment","doi-asserted-by":"publisher","award":["RTVU1202 (29336-HVMSTR-IRL)"],"award-info":[{"award-number":["RTVU1202 (29336-HVMSTR-IRL)"]}],"id":[{"id":"10.13039\/501100003524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bmcl.2026.130782","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:45:12Z","timestamp":1789800312000},"page":"130782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The antiproliferative and pro-apoptotic effects of 3-deoxy-3\u03b1-fluoro-chenodeoxycholic acid and 12\u03b2-methyl-3,7-dioxo-17-epi-25-homo-18-nor-5\u03b2-cholan-25-oic acid on human breast cancer cell lines"],"prefix":"10.1016","volume":"142","author":[{"given":"Divyashree","family":"Ravishankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Luxenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence D.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Dispa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Weymouth-Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Furneaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Linclau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M.I.","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130782_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bmcl.2026.130782_bb0010","article-title":"The anticancer activity of bile acids in drug discovery and development","volume":"15","author":"Li","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmcl.2026.130782_bb0015","doi-asserted-by":"crossref","first-page":"7184","DOI":"10.3390\/ijms23137184","article-title":"Mechanism of bile acid-induced programmed cell death and drug discovery against cancer: a review","volume":"23","author":"Jang","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130782_bb0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00018-022-04278-2","article-title":"The role of bile acids in carcinogenesis","volume":"79","author":"Re\u017een","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bmcl.2026.130782_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.778258","article-title":"Research progress of bile acids in cancer","volume":"11","author":"Fu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmcl.2026.130782_rf0030","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s11033-023-09106-9","article-title":"The obeticholic acid can positively regulate the cancerous behavior of MCF7 breast cancer cell line","volume":"51","author":"Rahmani","year":"2024","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.bmcl.2026.130782_rf0035","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3390\/cancers16071368","article-title":"FXR agonism with bile acid mimetic reduces pre-clinical triple-negative breast cancer burden","volume":"16","author":"Joseph","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130782_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210077","article-title":"The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma","volume":"14","author":"Di Matteo","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bmcl.2026.130782_rf0045","doi-asserted-by":"crossref","first-page":"14549","DOI":"10.1111\/jcmm.16083","article-title":"Farnesoid X receptor activation induces antitumour activity in colorectal cancer by suppressing JAK2\/STAT3 signalling via transactivation of SOCS3 gene","volume":"24","author":"Li","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.bmcl.2026.130782_or0005","doi-asserted-by":"crossref","unstructured":"Li S, Xu Z, Guo J, Zheng J, Sun X, Yu J. Farnesoid X receptor activation inhibits the growth and metastasis of colorectal cancer by suppressing JAK2\/STAT3 signaling via induction of the dissociation of the FXR\/\u03b2-catenin complex. Lancet preprint 2019, available at SSRN: https:\/\/ssrn.com\/abstract=3487715. Doi: https:\/\/doi.org\/10.2139\/ssrn.3487715.","DOI":"10.2139\/ssrn.3487715"},{"key":"10.1016\/j.bmcl.2026.130782_bb0045","doi-asserted-by":"crossref","first-page":"12502","DOI":"10.1038\/s41598-017-12629-4","article-title":"The FXR agonist, obeticholic acid, suppresses HCC proliferation & metastasis: role of IL-6\/STAT3 signalling pathway","volume":"7","author":"Attia","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2026.130782_bb0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-3835(00)00671-6","article-title":"Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells","volume":"163","author":"Ima","year":"2001","journal-title":"Cancer Lett"},{"issue":"8","key":"10.1016\/j.bmcl.2026.130782_bb0055","first-page":"613","article-title":"Modulation of the cell cycle and induction of apoptosis in human cancer cells by synthetic bile acids","volume":"6","author":"Kim","year":"2006","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.bmcl.2026.130782_bb0060","first-page":"231","article-title":"Synthetic bile acid derivatives inhibit cell proliferation and induce apoptosis in HT-29 human colon cancer cells","volume":"25","author":"Park","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bmcl.2026.130782_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2004.11.055","article-title":"Synthetic bile acid derivatives induce apoptosis through a c-Jun N-terminal kinase and NF-\u03baB-dependent process in human cervical carcinoma cells","volume":"229","author":"Im","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bmcl.2026.130782_bb0070","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.3390\/molecules24142644","article-title":"Novel derivatives of deoxycholic acid bearing linear aliphatic diamine and aminoalcohol moieties and their cyclic analogs at the C3 position: synthesis and evaluation of their in vitro antitumor potential","volume":"24","author":"Markov","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2026.130782_bb0075","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.3390\/molecules26195741","article-title":"Bile-acid-appended triazolyl aryl ketones: design, synthesis, in vitro anticancer activity and pharmacokinetics in rats","volume":"26","author":"Agarwal","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130782_bb0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.steroids.2012.09.009","article-title":"Synthesis and antitumor activity of N-sulfonyl-3,7-dioxo-5\u03b2-cholan-24-amides, ursodeoxycholic acid derivatives","volume":"78","author":"Ren","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.bmcl.2026.130782_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.steroids.2017.01.008","article-title":"Antitumor activity of newly synthesized oxo and ethylidene derivatives of bile acids and their amides and oxazolines","volume":"120","author":"Bjedov","year":"2017","journal-title":"Steroids"},{"key":"10.1016\/j.bmcl.2026.130782_bb0090","unstructured":"(a) Weymouth-Wilson AC, Packer G, Linclau BJP, Kydd-Sinclair D, Watson KA. Fluorinated bile acid derivatives. US 11,517,577 B2 (6.12.2022); (b)Weymouth-Wilson AC, Linclau BJP, Packer G, Watts J, Mortiboys H., Bandmann O, Hastings O. Fluorinated bile acids. US 2022\/0073557 A1 (10.03.2022); (c) b)Weymouth-Wilson AC, Linclau BJP, Packer G, Watts J, Mortiboys H., Bandmann O, Hastings O. 2-Fluorinated bile acids for the treatment of neurodegenerative diseases. WO 2020\/128514 Al (25.06.2020)."},{"issue":"38","key":"10.1016\/j.bmcl.2026.130782_bb0095","doi-asserted-by":"crossref","first-page":"25019","DOI":"10.1021\/acsomega.1c04199","article-title":"Synthesis of 12\u03b2-methyl-18-nor-bile acids","volume":"6","author":"Luxenburger","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmcl.2026.130782_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115143","article-title":"The discovery of 12\u03b2-methyl-17-epi-18-nor-bile acids as potent and selective TGR5 agonists","volume":"250","author":"Luxenburger","year":"2023","journal-title":"Eur J Med Chem"},{"issue":"14","key":"10.1016\/j.bmcl.2026.130782_bb0105","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1021\/acs.jmedchem.7b01788","article-title":"Fluorine and fluorinated motifs in the design and application of bioisosteres for drug design","volume":"61","author":"Meanwell","year":"2018","journal-title":"J Med Chem"},{"issue":"03","key":"10.1016\/j.bmcl.2026.130782_rf0110","first-page":"306","article-title":"Organic fluorine as a hydrogen-bond acceptor: recent examples and applications","volume":"47","author":"Champagne","year":"2015","journal-title":"Synthesis"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130782_rf0115","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1107\/S2052520617005923","article-title":"The hydrogen bond between N\u2014H or O\u2014H and organic fluorine: favourable yes, competitive no","volume":"73","author":"Taylor","year":"2017","journal-title":"Acta Crystallogr Sect B Struct Sci Cryst Eng Mater"},{"key":"10.1016\/j.bmcl.2026.130782_rf0120","first-page":"993","article-title":"Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells","volume":"9","author":"Wang","year":"2015","journal-title":"Drug Des Devel Ther"},{"issue":"10","key":"10.1016\/j.bmcl.2026.130782_rf0125","first-page":"4652","article-title":"Bardoxolone methyl (CDDO-me or RTA402) induces cell cycle arrest, apoptosis and autophagy via PI3K\/Akt\/mTOR and p38 MAPK\/Erk1\/2 signaling pathways in K562 cells","volume":"9","author":"Wang","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.bmcl.2026.130782_rf0130","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.607580","article-title":"Bardoxolone-methyl (CDDO-me) impairs tumor growth and induces radiosensitization of oral squamous cell carcinoma cells","volume":"11","author":"Hermann","year":"2021","journal-title":"Front Pharmacol"},{"issue":"14","key":"10.1016\/j.bmcl.2026.130782_rf0135","doi-asserted-by":"crossref","first-page":"9157","DOI":"10.1021\/acs.joc.2c00877","article-title":"Selectivity of oxidizing agents toward axial and equatorial hydroxyl groups","volume":"87","author":"Kaspar","year":"2022","journal-title":"J. Org. Chem."},{"issue":"18","key":"10.1016\/j.bmcl.2026.130782_rf0140","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1080\/00397919808004446","article-title":"Synthesis of analogues of brassinosteroids with 5\u03b2-cholanic acid skeleton","volume":"28","author":"Gil","year":"1998","journal-title":"Syn Commun"},{"key":"10.1016\/j.bmcl.2026.130782_bb0125","unstructured":"Li W-S; Hung W-C, Shen C-N. Sialyltransferase inhibitors and uses thereof. WO 2017\/035501 Al (2.3.2017)."},{"issue":"1","key":"10.1016\/j.bmcl.2026.130782_bb0130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1135\/cccc20020030","article-title":"3\u03b1-Fluoro analogues of \u201callopregnanolone\u201d and their binding to GABAA receptors","volume":"67","author":"Slav\u00edkov\u00e1","year":"2002","journal-title":"Collect Czechoslov Chem Commun"},{"key":"10.1016\/j.bmcl.2026.130782_bb0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1039\/c39790000065","article-title":"Convenient general preparation of oxygenated monofluoro- and gem-difluoro-5a-androstanes using diethylaminosulphur trifluoride","author":"Bird","year":"1979","journal-title":"J Chem Soc Chem Commun"},{"key":"10.1016\/j.bmcl.2026.130782_bb0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.steroids.2014.01.008","article-title":"Chemical synthesis, NMR analysis and evaluation on a cancer xenograft model (HL-60) of the aminosteroid derivative RM-133","volume":"82","author":"Maltais","year":"2014","journal-title":"Steroids"},{"issue":"12","key":"10.1016\/j.bmcl.2026.130782_bb0145","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.steroids.2012.07.004","article-title":"Neuroactive steroids with perfluorobenzoyl group","volume":"77","author":"\u010cern\u00fd","year":"2012","journal-title":"Steroids"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130782_bb0150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0039-128X(90)90021-3","article-title":"Lithium hydroxide\/aqueous methanol: mild reagent for the hydrolysis of bile acid methyl esters","volume":"55","author":"Dayal","year":"1990","journal-title":"Steroids"},{"issue":"10\u221211","key":"10.1016\/j.bmcl.2026.130782_bb0155","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.steroids.2011.05.004","article-title":"Norrish\u2013Prins reaction as a key step in the synthesis of 14\u03b2-hydroxy-5\u03b1 (or 5\u03b2 or \u03945,6)-pregnane derivatives","volume":"76","author":"Geoffroy","year":"2011","journal-title":"Steroids"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130782_bb0160","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1021\/ml200256d","article-title":"Avicholic acid: a lead compound from birds on the route to potent TGR5 modulators","volume":"3","author":"Pellicciari","year":"2012","journal-title":"ACS Med Chem Lett"},{"issue":"32","key":"10.1016\/j.bmcl.2026.130782_bb0165","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1016\/j.tetlet.2011.05.140","article-title":"A stereoselective synthesis of the Allo-bile acids from the 5\u03b2-isomers","volume":"52","author":"Li","year":"2011","journal-title":"Tetrahedron Lett"},{"issue":"22","key":"10.1016\/j.bmcl.2026.130782_bb0170","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1021\/jo01336a027","article-title":"Synthetic methods and reactions. 63. Pyridinium poly(hydrogen fluoride) (30% pyridine-70% hydrogen fluoride): a convenient reagent for organic fluorination reactions","volume":"44","author":"Olah","year":"1979","journal-title":"J Org Chem"},{"issue":"12","key":"10.1016\/j.bmcl.2026.130782_rf0190","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1021\/acsmedchemlett.7b00318","article-title":"Synthesis and biological evaluation of a series of bile acid derivatives as FXR agonists for treatment of NASH","volume":"8","author":"Xiao","year":"2017","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130782_or0020","unstructured":"Lei X, Wang, X, Li Y. Polycyclic compounds and methods thereof. WO 2023\/083343 Al (19.05.2023)."},{"key":"10.1016\/j.bmcl.2026.130782_bb0180","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.dyepig.2016.04.047","article-title":"Synthesis and characterization of novel dendritic compounds bearing a porphyrin core and cholic acid units using \u201cclick chemistry\u201d","volume":"132","author":"Aguilar-Ort\u00edz","year":"2016","journal-title":"Dyes Pigments"},{"key":"10.1016\/j.bmcl.2026.130782_bb0185","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1038\/s41598-021-84146-4","article-title":"Doxorubicin\u2013transferrin conjugate alters mitochondrial homeostasis and energy metabolism in human breast cancer cells","volume":"11","author":"Wigner","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130782_bb0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.54457\/DR.202402015","article-title":"Multifaced anticancer potential of doxorubicin: spotlight on breast cancer","volume":"5","author":"Swain","year":"2025","journal-title":"Dis Res"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130782_rf0210","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1021\/acs.jmedchem.9b01172","article-title":"Systematic investigation of lipophilicity modulation by aliphatic fluorination motifs","volume":"63","author":"Jeffries","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130782_rf0215","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jfluchem.2013.02.023","article-title":"On the polarity of partially fluorinated methyl groups","volume":"152","author":"Huchet","year":"2013","journal-title":"J Fluor Chem"},{"key":"10.1016\/j.bmcl.2026.130782_rf0220","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/hep.26208","article-title":"High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury","volume":"58","author":"Chen","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bmcl.2026.130782_rf0225","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3390\/ijms18071335","article-title":"Associations of drug lipophilicity and extent of metabolism with drug-induced liver injury","volume":"18","author":"McEuen","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2026.130782_bb0205","series-title":"Liver Pathophysiology","first-page":"767","article-title":"Chapter 55 - Ursodeoxycholic acid for the treatment of liver diseases","author":"Wang","year":"2017"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130782_bb0210","first-page":"162","article-title":"Ursodeoxycholic acid for the management of drug-induced liver injury: role of hepatoprotective and anti-cholestatic mechanisms","volume":"13","author":"Bessone","year":"2025","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.bmcl.2026.130782_bb0215","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/bcp.14311","article-title":"Effect of ursodeoxycholic acid on liver markers: a systematic review and meta-analysis of randomized placebo-controlled clinical trials","volume":"86","author":"Simental-Mend\u00eda","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130782_bb0220","doi-asserted-by":"crossref","first-page":"351","DOI":"10.7326\/0003-4819-97-3-351","article-title":"Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones","volume":"97","author":"Tint","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bmcl.2026.130782_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1732854","article-title":"Bile acids as therapeutic agents","volume":"16","author":"Vu","year":"2026","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130782_bb0230","first-page":"227","article-title":"A review of therapies for primary biliary cholangitis","volume":"22","author":"Alamgir","year":"2026","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.bmcl.2026.130782_bb0235","unstructured":"US Food and Drug Administration (FDA) meeting of the gastrointestinal drugs advisory committee \u2013 Minutes, May 19, 2023. https:\/\/www.fda.gov\/media\/169627\/download."},{"key":"10.1016\/j.bmcl.2026.130782_bb0240","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-0716-2553-8_16","article-title":"Cancer and apoptosis","volume":"2543","author":"Chaudhry","year":"2022","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130782_bb0245","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bmc.2013.11.029","article-title":"New highly toxic bile acids derived from deoxycholic acid, chenodeoxycholic acid and lithocholic acid","volume":"22","author":"M\u00e1jer","year":"2014","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130782_bb0250","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4143\/crt.2004.36.2.132","article-title":"Synthetic CDCA derivatives-induced apoptosis of stomach cancer cell line SNU-1 cells","volume":"36","author":"Moon","year":"2004","journal-title":"Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130782_bb0255","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.canlet.2008.05.014","article-title":"Synthetic chenodeoxycholic acid derivative, HS-1200, induces apoptosis of human hepatoma cells via a mitochondrial pathway","volume":"270","author":"Liu","year":"2008","journal-title":"Cancer Lett"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130782_bb0260","first-page":"979","article-title":"Apoptotic activity of novel bile acid derivatives in human leukemic T cells through the activation of caspases","volume":"18","author":"Choi","year":"2001","journal-title":"Int J Oncol"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26002490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26002490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:12:16Z","timestamp":1793909536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26002490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":61,"alternative-id":["S0960894X26002490"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130782","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antiproliferative and pro-apoptotic effects of 3-deoxy-3\u03b1-fluoro-chenodeoxycholic acid and 12\u03b2-methyl-3,7-dioxo-17-epi-25-homo-18-nor-5\u03b2-cholan-25-oic acid on human breast cancer cell lines","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"130782"}}